30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mor George Adi

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mor George Adi's trades of Chemomab Therapeutics Ltd's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-05 2023-01-03
PlS Planned sale
68,670 +4.4%
499.06
US$911,302 		68,670 +4.4% 499.06 US$911,302
2023-01-05 2023-01-03
PlS Planned sale
85,419 -20.5%
254.79
US$3,691,179 		85,419 -20.5% 254.79 US$3,691,179
2022-11-17 2022-11-16
S Sale
23,211 -9.5%
293.16
US$918,810 		23,211 -9.5% 293.16 US$918,810
2022-11-17 2022-11-16
S Sale
324,775 -50.0%
2.08
US$677,091 		324,775 -50.0% 2.08 US$677,091